Since the writing of this article, C.CAN has begun trading as C.IN “InMed Pharmaceuticals.”
TDM Financial
In this segment we will be talking to Mr. Craig Schneider, CEO of Cannabis Technologies.
Cannabis Technologies is a biopharmaceutical drug discovery and development company uniquely focused on the pharmacology and therapeutic potential of cannabinoids.
CTI is utilizing its proprietary “Cannabinoid Drug Design Platform” to identify new bioactive compounds within the marijuana plant that interact with certain genes responsible for specific diseases.
Their extensive research and intellectual properties will initially be focused on the development of several new cannabinoid based treatments for Ocular Cancer and Angiogenesis, as well as Inflammation and Pain.
Cannabis Technologies is a publicly traded company listed in the US under ticker symbol CANLF.